Linked Life Data

8072871

Source:http://linkedlifedata.com/resource/pubmed/id/8072871

Statements in which the resource exists as a subject.
PredicateObject
rdf:type
lifeskim:mentions
pubmed:issue
8
pubmed:dateCreated
1994-9-28
pubmed:abstractText
We analyzed the safety of the segmental-subsegmental TAE for hepatocellular carcinoma in 18 cases of liver hypofunction by checking total bilirubin change after TAE. The TAE was performed safely in all of the cases. The highest value of total bilirubin before TAE was 5.1 mg/dl in the 1-2 subsegment TAE group, 3.8 mg/dl in the 3-4 subsegment TAE group and 2.0 mg/dl in the 6 subsegment TAE group. We conclude that segmental TAE is safe even in the patient of liver hypofunction.
pubmed:language
jpn
pubmed:journal
pubmed:citationSubset
IM
pubmed:chemical
pubmed:status
MEDLINE
pubmed:month
Jul
pubmed:issn
0048-0428
pubmed:author
pubmed:issnType
Print
pubmed:day
25
pubmed:volume
54
pubmed:owner
NLM
pubmed:authorsComplete
Y
pubmed:pagination
798-800
pubmed:dateRevised
2011-7-26
pubmed:meshHeading
pubmed:year
1994
pubmed:articleTitle
[Usefulness and safety of segmental-subsegmental TAE for hepatocellular carcinoma in cases of liver hypofunction].
pubmed:affiliation
Department of Radiology, Kyoto 2nd Red cross Hospital.
pubmed:publicationType
Journal Article, English Abstract